B-Harmony: WuXi And MedImmune Establish JV To Seize Biologics Growth In China
This article was originally published in PharmAsia News
Executive Summary
WuXi’s joint venture with MedImmune could have ripple effects for other multinational biotechs aiming to develop biologics for China.